ASP-7713
- Generic Name
- ASP-7713
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy Japanese Adult Subjects
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Astellas Pharma Europe B.V.
- Target Recruit Count
- 40
- Registration Number
- NCT03108755
- Locations
- 🇬🇧
Site GB44001, Harrow, Middlesex, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath